Grifols Antithrombin Research Awards
Forecasted
Grifols Antithrombin Research Awards support scientists and clinicians investigating current and new therapeutic uses of antithrombin to deepen understanding and inform clinical or medical practice.
Funder: Grifols
Due Dates (Anticipated): January 2027 (Letter of Intent)
Funding Amounts: One annual grant of EUR 50,000 for 12 months
Summary: Supports research into current and new therapeutic uses of antithrombin.
Key Information: Applicants first submit a Letter of Intent; selected candidates are invited to submit a full proposal.
Description
The Grifols Antithrombin Research Awards support projects investigating current and new uses of antithrombin as a therapeutic product. The program is open to scientists and clinicians with innovative ideas that could deepen understanding of those uses, whether they work individually or in teams at hospitals, universities, or independent institutions.
Grifols also aims to build lasting cooperation with participating researchers and clinicians, strengthen connections between researchers and the company, and foster relationships with key opinion leaders across different fields. Proposals are assessed for scientific merit, innovation, clinical or medical impact, and the quality of the research environment.
